Quality of Life in Advanced Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy

NCT04408859 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 290

Last updated 2020-05-29

No results posted yet for this study

Summary

The purpose of this study is to explore the influence of neoadjuvant chemotherapy in the long term quality of life with advanced gastric cancer patients.

Conditions

  • QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy

Interventions

DRUG

Neoadjuvant Chemotherapy

The patients receive neoadjuvant chemotherapy for 2-4 cycles before surgery.

Sponsors & Collaborators

  • Peking University Cancer Hospital & Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-17
Primary Completion
2022-01-10
Completion
2022-01-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04408859 on ClinicalTrials.gov